BioSpace News Archive

Veru Inc. today announced it will host a conference call and audio webcast on Thursday, August 10, 2023, at 8:00 a.m. ET to discuss its fiscal 2023 third quarter financial results and to provide a business update.

Longboard Pharmaceuticals, Inc. today announced members of its leadership team will present at the BTIG Virtual Biotechnology Conference and the Wedbush Annual PacGrow Healthcare Conference in New York City.

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company’s founder, president and CEO, is presenting at an invitation-only lunch gathering of the Wall Street Wonders Investment Group in New York City at 1:30 p.m. EDT on Friday August 4, 2023.

Cyclacel Pharmaceuticals, Inc. will announce second quarter 2023 financial results on Wednesday August 9, 2023. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time on the same day.

Acclaro Medical announced the launch of UltraClear Laser-Coring, the first-of-its-kind laser to enable tissue coring to improve deep wrinkles, deep scars, and other age-related issues on all skin types with minimal discomfort and downtime.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study.

ImmunityBio, Inc. ( NASDAQ: IBRX ), a clinical-stage immunotherapy company, today announced that it has named Enrique Diloné, Ph.D., to the newly created role of Chief Technology Officer.

iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions announced the appointment of Dr. Michael Lutz as CEO and Director for Iota Sciences Ltd.

BostonGene announced today that it will participate in and present at the 11th Annual Immuno-Oncology Summit, the leading annual meeting focusing on the next wave of biotherapeutics, advances in technologies, and the valuable exchange of high-quality research from all disciplines of immuno-oncology, which is being held August 7 – 9, 2023 in Boston, MA.

Medovate Ltd announced its SAFIRA™ has received an Innovative Technology contract from Vizient, Inc. the nation’s largest member-driven healthcare performance improvement company.